<DOC>
	<DOCNO>NCT00279292</DOCNO>
	<brief_summary>This clinical trial determine effective method control pain pancreatic cancer . Although narcotic pain medication effective , many side effect underutilized due social stigma fear addiction . Celiac plexus neurolysis nerve block procedure show effective uncontrolled clinical trial . We hypothesize celiac plexus neurolysis plus pain medication effective few side effect pain medication alone . We evaluate effectiveness standard pain medication without celiac plexus neurolysis randomize control trial . One half participant receive pain medication half receive pain medication plus neurolysis , deliver via endoscopic ultrasound device place stomach .</brief_summary>
	<brief_title>Randomized Trial EUS Neurolysis Pancreas Cancer</brief_title>
	<detailed_description>This phase III randomize blind sham control trial endoscopic ultrasound guide celiac plexus neurolysis . Patients pancreatic cancer unresectable significant pain ( &gt; 3 0-10 scale ) enrol . At time stag endoscopic ultrasound , patient randomize celiac neurolysis sham ( injection medication lumen stomach ) . Neurolysis perform use standard bupivicaine ethanol . Patients follow least 3 month pain , quality life narcotic usage .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>3.1 Unresectable ( T4 M1 nonregional lymph node ) inoperable ( due medical comorbidity ) carcinoma pancreas determine CT EUS . Patients extensive portal vein superior mesenteric vein involvement ( T3 6th Ed . AJCC stag manual ) include consult surgeon feel patient unresectable base CT scan information . 3.2 Presence midabdominal pain ( 3 VAS scale ) least 2 day per week , last least 1 hour per day . 3.3 No know coagulopathy measure Prothrombin time ( INR ) 1.5 . PreEUS INR require unless clinically indicate due know warfarin use suspect coagulopathy . 3.4 Patient must require 2 l/min oxygen supplementation maintain saturation &gt; 90 % . 3.5 &gt; 6 month since previous myocardial infarction angina . 3.6 ≥ 4 week since previous surgery . 3.7 No institution change chemotherapy radiotherapy within 7 day prior ( 14 day post ) ESUCPN . See section 7.0 7.1 detail chemotherapy radiotherapy allowance . 3.8 Platelets ≥ 50,000 . PreEUS CBC require unless clinically indicate due know suspected coagulopathy . 3.9 Life expectancy &gt; 3 month 3.10 Signed date informed consent . Unable sign inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Pancreatic neoplasm</keyword>
</DOC>